1980
DOI: 10.1016/s0022-5347(17)55500-7
|View full text |Cite
|
Sign up to set email alerts
|

Serum Alpha-Fetoprotein and Human Chorionic Gonadotropin in Patients with Seminoma

Abstract: We analyzed the case histories of 31 patients who initially had a diagnosis of seminoma and elevated serum levels of alpha-fetoprotein or human chorionic gonadotropin. We concluded that an elevated alpha-fetoprotein level is firm evidence of the presence of non-seminomatous germ cell tumor and that the patient should be treated accordingly. However, if the level of human chorionic gonadotropin alone is elevated the diagnosis may be either non-seminomatous tumor or seminoma. Patients with seminoma and an elevat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
13
0
1

Year Published

1982
1982
2017
2017

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 72 publications
(14 citation statements)
references
References 20 publications
0
13
0
1
Order By: Relevance
“…Some investigators have considered the detection of AFP in the serum of patients with metastatic seminoma indicates the appearance of occult teratoma (Lange et al, 1980). Others have regarded the appearance of this marker as supporting the idea that seminoma is an intermediate pathological state which evolves to either AFP-or HCG-secreting teratoma (Raghavan et al, 1982).…”
Section: Serum Samplesmentioning
confidence: 99%
“…Some investigators have considered the detection of AFP in the serum of patients with metastatic seminoma indicates the appearance of occult teratoma (Lange et al, 1980). Others have regarded the appearance of this marker as supporting the idea that seminoma is an intermediate pathological state which evolves to either AFP-or HCG-secreting teratoma (Raghavan et al, 1982).…”
Section: Serum Samplesmentioning
confidence: 99%
“…In 1980, Lange et al declared "an elevated AFP level is incontrovertible evidence of non-seminomatous tumor and the patient should be treated accordingly" [16] . Apparently, that dictum is facing challenge today, because there is growing evidence of the occurrence of non-pathologic AFP elevations in seminoma patients.…”
mentioning
confidence: 99%
“…The absence of AFP in seminomas is a generally rec ognized fact [ 19,21 ]. If a tumor classified as a seminoma by histology proves AFP-positive, it is to be regarded as a mixed tumor with portions of yolk sac tumor [4,14].…”
Section: Discussionmentioning
confidence: 99%